链霉菌ZG0429的分类鉴定与链霉亲和素的分离纯化研究

从土壤中筛选得到1株高产链霉亲和素的放线菌ZG0429,根据形态观察、培养特征、生理生化鉴定以及16S rRNA序列分析,初步判定该菌株为链霉菌属中的淡紫灰链霉菌(Streptomyces lavendulae)。经发酵,ZG0429的链霉亲和素产量可达201.0mg/L。进一步采用硫铵沉淀和凝胶过滤层析纯化,链霉亲和素的回收率为76.87%,纯度可以达到97.03%。该方法简单易行,成本低廉,可得到高产量、高纯度、高活性的目的蛋白,为链霉亲和素发酵产品的大规模纯化提供了依据。     

链霉菌ACCC40021的多基因系统进化分析

链霉菌ACCC40021是尹莘耘1953年分离筛选,用于农业生产的抗生菌肥。该菌株1979年经鉴定为泾阳链霉菌(Streptomyces jingyangensis),但该菌株名称一直没有在国际上得到有效发表。为了在分子水平上明确该菌株的分类地位,对ACCC40021的菌株进行了16SrRNA和gyrB,recA,rpoB和trpB等基因的进化分析,将ACCC40021鉴定为黄赭色链霉菌(Streptomyces silaceus)。     

一株高产木聚糖酶的枝链霉菌的分离鉴定及产酶

对1株高产木聚糖酶的链霉菌进行了鉴定并研究其木聚糖酶的生产过程及水解产物特点。分离得到1株产木聚糖酶的链霉菌Streptomyces sp.L2001,从形态学特征、培养特征和生理生化特征等方面对该菌株进行了鉴定。PCR扩增得到16S rDNA序列全长为1429bp,分析结果表明,菌株与Streptomyces rameus NBRC3782同源性达99.16%。结合传统生理生化实验结果鉴定为枝链霉菌。菌株液体发酵6d能产生842.0U/mL木聚糖酶活力。经HPLC分析酶解产物,结果显示木二糖、木三糖及木四糖含量之和高达93.5%,该酶适用于工业化生产低聚木糖。     

链霉菌IMS002的分类鉴定及其抗真菌活性物质解析

【目的】对一株分离自植物根际土壤的具有抗真菌活性的链霉菌IMS002进行菌株分类鉴定,通过活性追踪分离纯化并鉴定有机相中的活性物质。【方法】通过16S rDNA和5个不同基因(atpD,gyrB,recA,rpoB,trpB)串联聚类分析以及生理生化实验分析,对链霉菌IMS002进行菌株分类鉴定,用扫描电子显微镜观察该株链霉菌的菌丝及孢子形态,以尖孢镰刀菌(Fusarium oxysporum)为指示菌进行生物活性追踪,通过硅胶柱层析、凝胶柱层析及高压液相色谱(HPLC)对活性物质进行分离和纯化,使用液质联用高分辨质谱仪、500 MHz核磁共振波谱仪以及圆二色光谱仪确定该物质的化学结构。【结果】IMS002经初步鉴定与产二素链霉菌(Streptomycesambofaciens)具有较近的亲缘关系,其发酵液对尖孢镰刀菌具有良好的抑菌效果,经分离和纯化以及现代波谱技术分析,确定有机相中的抑菌活性组分为Borrelidin。【结论】链霉菌IMS002能够产生化合物Borrelidin,该化合物对尖孢镰刀菌具有抑制活性。     

高温链霉菌24＃的初步研究

从土壤中筛选得到一株产广谱、高活性抗真菌物质的链霉菌 2 4 # ,经测定对 2 5种植物病原真菌有显著拮抗作用 ,其次生代谢产物对病菌菌丝有断裂、扭曲、缢缩等致畸效应。 16SrDNA序列分析显示本菌株与模式菌株链霉菌DSM4 4 2 93T的 16SrDNA同源性为 98 93% ,但菌株形态特征、培养特征、细胞壁化学组分、生理生化特性等均不同于模式菌株 ,且DNA杂交率只有 2 2 5 4 % ,建议为链霉菌属的一个新种 ,命名为山东链霉菌 (Streptomycesshandon gensissp .nov .)。     

黑暗链霉菌DNA转移系统的建立

研究了黑暗链霉菌的基因转移系统,探索了通过PEG介导的原生质体转化、接合转移向黑暗链霉菌中转入外源DNA的可能性。多次尝试用质粒pIJ702转化黑暗链霉菌9904原生质体均未成功。对原生质体进行“热处理”后转化、利用单链DNA转化等都不能将质粒导入黑暗链霉菌中,表明黑暗链霉菌对外源DNA有很强的限制修饰作用。利用接合转移将具有oriT的大肠杆菌链霉菌穿梭质粒pHZ132转入大肠杆菌ET12567(pUZ8002)中,获得供体菌ET12567(pUZ8002,pHZ132)。将供体菌与预萌发的黑暗链霉菌9904的孢子进行接合转移,成功地将pHZ132转入黑暗链霉菌9904中。质粒pHZ132经黑暗链霉菌自身修饰后也可转入黑暗链霉菌9904菌株的原生质体中,转化率约为103/μg DNA(pHZ132)。     

链霉菌科分类的研究III．链霉菌科中的一个新属

从我国云南省西双版纳热带植物研究所的土壤中分离到二株菌,编号80—56、80 57。该菌株气丝形成非轮生的孢子链,基内菌丝体不断裂,形态与培养特征与链霉菌属基本相似。但由于细胞壁水解物中含有…o一二氨基庚二酸、甘氨酸。全细胞水解物中含有半乳糖,与链霉菌属胞壁组分含LL二氨基庚二酸、甘氨酸,不含特征性糖有明显区别。故菌株80—56、80一57不能归人到过去任何一个放线菌属中,因此建立新属——类链霉菌属(Streptomycoides n.gen．),此二菌株为该新属的代表种,定名为青黄类链霉菌(Streptomycoides glaucoflavus n.sp．),典型菌株80—56。     

一株链霉菌21-1的分离鉴定及其对禾谷镰刀菌的抑菌活性

【背景】由禾谷镰刀菌(Fusarium graminearum)引起的小麦赤霉病严重威胁我国的小麦生产。【目的】筛选对禾谷镰刀菌具有拮抗能力的链霉菌菌株,为生防菌剂开发提供理论基础。【方法】利用平板对峙法筛选对禾谷镰刀菌具有拮抗能力的链霉菌;通过形态特征、生理生化特征和16S rRNA基因序列分析对其进行鉴定;通过病原菌菌丝生长、孢子产生及萌发抑制试验分析其发酵液的抑菌活性;利用人工接种试验测定该菌株发酵液的防病效果。【结果】筛选到一株对禾谷镰刀菌具有较强拮抗活性的链霉菌21-1,抑菌率为59.5%。依据形态特征、生理生化特性和16S rRNA基因序列分析,将该菌株鉴定为黄三素链霉菌(Streptomycesflavotricini)。菌株21-1发酵液能够抑制禾谷镰刀菌的菌丝生长、孢子产生及萌发过程,而且可以降低禾谷镰刀菌菌丝中可溶性蛋白质的含量,并增加丙二醛的含量。菌株21-1可以产生蛋白酶及纤维素酶。菌株21-1菌液10倍稀释液对小麦赤霉病的防效最佳,为70.1%。此外,菌株21-1发酵液对其他8种植物病原菌均有较好的抑制作用。【结论】菌株21-1对禾谷镰刀菌有较好的抑菌活性,具...     

链霉菌6803菌株对植物的化感作用

链霉菌属是绝大多数已知抗生素和一些重要活性物质的产生菌,它对高等植物是否具有化感作用尚缺乏研究. 从土壤中分离获得7个放线菌菌株,研究其对植物幼苗生长的抑制作用.结果表明： 链霉菌6803菌株在固体和液体发酵培养时均强烈抑制油菜根和稗草根的生长, 其液体发酵液的5倍稀释液对油菜和稗草苗生长的抑制分别达到60.7%和61.3%. 常规形态与生理生化试验表明,该菌株属于链霉菌属金色类群; 16S rRNA基因序列分析表明,该菌株为沙场链霉菌,基因序列相似性达到99.28%. 此菌株经过80～100 s紫外线照射筛选出的正突变菌株UV8024和UV100-2的10倍稀释发酵液对油菜幼苗生长的抑制作用比原始菌株分别提高了37.5%和38.1%, 经过1%硫酸二乙酯诱变50 min筛选出的正突变菌株D507的10倍稀释发酵液对油菜幼苗生长的抑制作用比原始菌株提高了29.8%. 链霉菌6803菌株对高等植物具有化感作用, 并可通过诱变育种提高其化感潜力.     

离子注入选育高产壮观链霉菌的研究

利用离子注入选育高产壮观链霉菌。壮观链霉菌1043为一壮观霉素生产菌种,通过实验建立了离子注入选育壮观链霉菌。其效价较出发菌株提高了102.3%。     

Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil

Pravastatin is one of the first available statins on the market. The purpose of this study was to isolate and identify the quinoline-degrading microorganism from petroleum-contaminated soil that could bioconvert compactin to pravastatin. There were 10,011 microorganism colonies isolated; five strains showed a higher capability for quinoline biodegradation. These five strains were evaluated for their pravastatin bioconversion ability; Pseudonocardia sp. had the highest efficiency for conversion of compactin to pravastatin. The strain was further identified as Pseudonocardia carboxydivorans PAH4. The bioconversion rates were studied under difference incubation conditions. Pre-incubation in medium containing 0.005% compactin sodium, resulted in the compactin utilization rate of almost 100% in a 1mg/ml compactin-containing medium. The rate of conversion of pravastatin was up to 68% after 6 days of incubation. In conclusion, the results of this study suggest that P. carboxydivorans PAH4 could be considered a candidate for the production of pravastatin on an industrial scale.     

Screening of Compactin-Resistant Microorganisms Capable of Converting Compactin to Pravastatin

A simple method of using compactin for effective screening of microbial strains with high hydroxylation activity at the 6β position of compactin was developed. Agar plates containing different carbon sources and 500 μg compactin mL⁻¹ were used to screen the microorganisms that can convert compactin to pravastatin. About 100 compactin-resistant strains were isolated from the Basal agar containing 7% (w/v) mannitol as a carbon source, in which two bacteria, Pseudomocardia autotrophica BCRC 12444 and Streptomyces griseolus BCRC 13677, capable of converting compactin to pravastatin with the yield of 20 and 32% (w/w), respectively, were found. High-performance liquid chromatography using C-18 column and two sequential mobile phases, 30% and 50% (v/v) acetonitrile, was also established to simultaneously determine the concentration of compactin and pravastatin in the culture broth. As such, about 2% of target microorganisms could be obtained from the screening program.     

Bioconversion of compactin into pravastatin by Streptomyces sp.

Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l^–1 from 750 mg compactin l^–1 in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l^–1 and 1000 mg pravastatin l^–1, respectively, with the conversion rate of 10 mg l^–1 h^–1. Continuous feeding of compactin increased production of pravastatin to 15 mg l^–1 h^–1.     

Strain Improvement of Streptomyces xanthochromogenes RIA 1098 for Enhanced Pravastatin Production at High Compactin Concentrations

Pravastatin is one of the most popular cholesterol-lowering drugs. Its industrial production represents a two-stage process including the microbial production of compactin and its further biocatalytic conversion to pravastatin. To increase a conversion rate, a higher compactin content in fermentation medium should be used; however, high compactin concentrations inhibit microbial growth. Therefore, the improvement of the compactin resistance of a producer still remains a relevant problem. A multi-step random UV mutagenesis of a Streptomyces xanthochromogenes strain RIA 1098 and the further selection of high-yield compactin-resistant mutants have resulted in a highly productive compactin-resistant strain S 33-1. After the fermentation medium improvement, the maximum bioconversion rate of this strain has reached 91 % at the daily compactin dose equal to 1 g/L and still remained high (83 %) even at the doubled dose (2 g/L). A 1-year study of the mutant strain stability has proved a stable inheritance of its characteristics that provides this strain to be very promising for the pravastatin-producing industry.

Electronic supplementary material

The online version of this article (doi:10.1007/s12088-015-0537-5) contains supplementary material, which is available to authorized users.     

Rapid detection and isolataion of DNA-binding compounds: from Streptomyces xanthochromogenes

J. HOLMALAHTI, S. JUNTTILA AND A. VON WRIGHT. 1996. The culture medium of Streptomyces xanthochromogenes JH903 was found to show selective activity against DNArepair-deficient Escherichia coli CM871 strain. In this report we describe a simple method to locate and isolate DNA binding compounds from the fermentation broth. The method is based on the retention of DNA-reacting compounds in cellulose complexed with DNA, and purification of these compounds with thin-layer chromatography. Screening of microbial metabolites from chloroform extracts of fermentation media resulted in detection of five genotoxic fractions.     

Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin

An automatic feeding process for microbial hydroxylation of ML236B sodium salt (ML-236B Na; compactin) by Streptomyces carbophilus SANK 62585 was developed. The hydroxylated product, pravastatin sodium salt (pravastatin; trade name Mevalotin), is an inhibitor of 3-hydroxy-3-methyglutaryl-coenzyme A reductase (HMG-CoA reductase) used as cholesterol-lowering drug. The hydroxylation activity of S. carbophilus was induced by the addition of ML236B Na to culture broth but inhibited by high concentration of ML236B Na. In order to obtain high conversion yield, it was necessary to maintain optimum ML236B Na concentration throughout the fermentation by continuous feeding. For this purpose, we developed an on-line monitoring method, which mainly consisted of a cross-flow filtration module, high-performance liquid chromatography (HPLC) analyzer, feed pump, and microcomputer for regulation of ML236B Na concentration. An algorithm for control of ML236B Na feed rate based on feedback and feed-forward control where conversion rate after Deltat was estimated by using regression analysis of the five latest values of conversion rate. In a fed-batch culture employing this system, the concentration of ML236B Na was maintained at optimum level during the fermentation and the productivity of pravastatin was increased threefold over that obtained in manual control culture. (c) 1993 John Wiley & Sons, Inc.     

产帕曲星菌株的选育、抗菌物质纯化及结构鉴定

链霉菌SIPI—A．2020是本实验室分离保藏的一株可能产生帕曲星的放线菌,本文对此菌株培养与发酵、抗菌活性物质的分离纯化及其结构验证进行了研究。经过菌种选育与发酵条件优化,与出发菌株相比,主要发酵产物X的发酵效价提高89．3％;通过对发酵液的分离纯化,得到了HPLC纯度分别为96．3％和95．6％的两个组分,经进一步UV、MS、NMR等分析,验证其为帕曲星B和帕曲星A。     

Purification and characterization of recombinant Streptomyces griseus aminopeptidase

Recombinant Streptomyces griseus aminopeptidase (SGAP) was produced using Cangene's expression system, CANGENUS. This heat-stable aminopeptidase with an N-terminal Ala-Pro-Asp-Ile-Pro-Leu-Ala-Asn-Val-Lys-Ala sequence was purified from 16L of Streptomyces lividans fermentation supernatant with high purity and 19.5% recovery rate. This was achieved by the combination of hydrophobic-interaction and size-exclusion chromatographic procedures. The calcium-activated zinc metalloprotein demonstrated no loss of activity at -20 degrees C for at least 8 weeks in both liquid and freeze-dried formulations. The recombinant SGAP showed an apparent molecular mass of 31 kDa by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and 26.8 kDa by gel filtration. The simple, high-yield, inexpensive purification method with few intermediate steps provides a novel and practical procedure for large-scale production of active recombinant S. griseus aminopeptidase.     

Optimisation of aqueous two-phase extraction of human antibodies

The purification of human antibodies in an aqueous two-phase system (ATPS) composed of polyethylene glycol (PEG) 6000 and phosphate was optimised by surface response methodology. A central composite design was used to evaluate the influence of phosphate, PEG and NaCl concentration and of the pH on the purity and extraction yield of IgG from a simulated serum medium. The conditions that maximise the partition of IgG into the upper phase were determined to be high concentrations of NaCl and PEG, low concentrations of phosphate and low pH values. An ATPS composed of 12% PEG, 10% phosphate, 15% NaCl at pH 6 was further used to purify human monoclonal antibodies from a Chinese Hamster Ovary (CHO) concentrated cell culture supernatant with a recovery yield of 88% in the upper PEG-rich phase and a purification factor of 4.3. This ATPS was also successfully used to purify antibodies from a hybridoma cell culture supernatant with a recovery yield of 90% and a purification factor of 4.1.